Dianthus Therapeutics
DNTH
DNTH
91 hedge funds and large institutions have $859M invested in Dianthus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5.66% more ownership
Funds ownership: 101.2% → 106.86% (+5.7%)
0% more call options, than puts
Call options by funds: $11K | Put options by funds: $11K
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
91
Holding in Top 10
5
Calls
$11K
Puts
$11K
Top Buyers
| 1 | +$27.3M | |
| 2 | +$11.3M | |
| 3 | +$7.48M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.21M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$4.11M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$9.58M | |
| 3 | -$6.47M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$5.61M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$1.7M |